Sfoglia per AUTORE
FOX SB
Collezione AOU San Luigi di Orbassano

  

Items : 10

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010). in Journal of the National Cancer Institute. Monographs / J Natl Cancer Inst Monogr. 2011;2011(43):147-51. doi: 10.1093/jncimonographs/lgr037.

2011
AOU San Luigi di Orbassano

Berruti A; Generali D; Kaufmann M; Puztai L; Curigliano G; Aglietta M; Gianni L; Miller WR; Untch M; Sotiriou C; Daidone M; Conte P; Kennedy D; Damia G; Petronini P; Di Cosimo S; Bruzzi P; Dowsett M; Desmedt C; Mansel RE; Olivetti L; Tondini C; Sapino A; Fenaroli P; Tortora G; Thorne H; Bertolini F; Ferrozzi F; Danova M; et alii...

Molecular oncology and the neoadjuvant setting: The perfect blend for treatment personalization and clinical trial design in Journal of the National Cancer Institute - Monographs

2011
AOU San Luigi di Orbassano

Generali D; Berruti A; Foroni C; Bazzola L; Andreis D; Allevi G; Bersiga A; Dogliotti L; Fox SB; Harris AL; Bottini A;

Predictive immunohistochemical biomarkers in the context of neoadjuvant therapy for breast cancer in Journal of the National Cancer Institute - Monographs

2011
AOU San Luigi di Orbassano

Generali D; Symmans WF; Berruti A; Fox SB;

The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1? and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen in Breast Cancer Research

2011
AOU San Luigi di Orbassano

Fox SB; Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Mele T; Dogliotti L; Bottini A; Harris AL;

Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients in Clinical Cancer Research

2009
AOU San Luigi di Orbassano

Generali D; Bates G; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Dogliotti L; Banham AH; Harris AL; Bottini A; Fox SB;

Mammaprint®: Predictive tool of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients in Annals of Oncology

2008
AOU San Luigi di Orbassano

Generali DG; Bazzola L; Foroni C; Berruti A; Dogliotti L; Fox SB; Bottini A;

Down-regulation of phosphatidylinositol 3?-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer in Clinical Cancer Research

2008
AOU San Luigi di Orbassano

Generali D; Fox SB; Brizzi MP; Allevi G; Bonardi S; Aguggini S; Milani M; Bersiga A; Campo L; Dionisio R; Vergoni F; Giardini R; Dogliotti L; Bottini A; Harris AL; Berruti A;

Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer in Clinical Cancer Research

2007
AOU San Luigi di Orbassano

Generali D; Fox SB; Berruti A; Moore JW; Brizzi MP; Patel N; Allevi G; Bonardi S; Aguggini S; Bersiga A; Campo L; Dogliotti L; Bottini A; Harris AL;

Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer in Endocrine-Related Cancer

2006
AOU San Luigi di Orbassano

Generali D; Fox SB; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield SM; Bruzzi P; Bersiga A; Allevi G; Milani M; Aguggini S; Dogliotti L; Bottini A; Harris AL;

Hypoxia-inducible factor-1? expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer in Clinical Cancer Research

2006
AOU San Luigi di Orbassano

Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield S; Bersiga A; Allevi G; Milani M; Aguggini S; Gandolfi V; Dogliotti L; Bottini A; Harris AL; Fox SB;